The 2026 Biotech Divide: When Generative Biology Meets the FDA WallGlobal Report·5 hours agoINM-3.24%TXG-4.57%
Cathie Wood Scoops Up Tesla Shares as Stock Sinks, Ark Trims Robinhood Amid Crypto Weaknessbenzinga_article·11 hours agoFIG+3.20%IRDM-3.02%
Biotech Stocks At 52-Week Highs - CPHI Soars +790%, XNCR, ETON, TXG, ACHCrttnews·2 days ago, 04:48 AMETON-1.54%CPHI-9.46%
Corporate Restructurings and AI Pivots Dominate Mid-2026 Strategic ShiftsGlobal Report·2 days ago, 04:17 AMCPNG-0.42%GEMI-4.20%
The Great Biotech Reckoning: When AI and Gene Editing Meet Wall Street's Patience in 2026Global Report·Jul 19 at 04:13 AMAMGN+1.73%CRSP-1.73%
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 TrajectoryGlobal Report·Jul 18 at 04:13 AMAMGN+1.73%CRSP-1.73%
ARK Invest snaps up $16.7M in SPCX shares, trims Deere exposureMSN·Jul 16 at 03:57 AMTWST-2.92%TXG-4.57%
Cathie Wood Bets $16.6 Million on SpaceX as Elon Musk's Rocket Company Falls Below IPO Pricebenzinga_article·Jul 15 at 09:38 PMTXG-4.57%SPCX-5.67%
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026PR Newswire·Jul 15 at 03:05 PMTXG-4.57%
Top 3 Health Care Stocks That May Implode This Monthbenzinga_article·Jul 15 at 07:56 AMPRVA+2.08%TXG-4.57%
Biotech Stocks At 52-Week Highs - COAG, ALMR, PGNY, TXG, VMDrttnews·Jul 14 at 03:05 AMVMD+1.03%PGNY+0.55%
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% DownsideTradingView·Jul 13 at 11:20 AMTXG-4.57%